Skip to content

Sleep Screening and Intervention for Adolescents With Type 1 Diabetes in a Clinical Diabetes Center

Sleep Screening and Intervention for Adolescents With Type 1 Diabetes in a Clinical Diabetes Center

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07494188
Enrollment
50
Registered
2026-03-27
Start date
2026-02-23
Completion date
2026-12-01
Last updated
2026-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

Type 1 diabetes, Adolescents, Sleep health

Brief summary

This study is evaluating an in-clinic sleep screening and intervention algorithm for youth with type 1 diabetes. This study will assess health care provider feasibility of completion of intervention and long term follow up for adolescents with T1D.

Detailed description

This study involves enrollment of adolescents with T1D in conjunction with a diabetes health care provider at the Barbara Davis Center. Adolescents will complete a sleep screening questionnaire prior to the clinic visit. If the adolescent screens positive for sleep concerns, they will complete an indepth questionnaire to identify the barriers to sleep and this information will be provided to the health care provider. During the routine T1D clinic visit, the health care provider will be provided with the questionnaire answers and sleep interventions, and will address these at their discretion throughout the clinical encounter. Adolescents enrolled in the study will be follow at 3 months. For those that screened positive for sleep concerns, questionnaires will be completed related to the intervention to determine completion, retention, and follow through. Those who did not screen positive, will additionally complete a follow up sleep screener to assess consistency in their sleep health.

Interventions

Adolescents that screen positive for sleep concerns will receive targeted interventions based on their self-reported sleep barriers. These will be provided by the health care provider.

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
11 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Type 1 diabetes * Receiving care at the Barbara Davis Center * Using a continuous glucose monitor

Exclusion criteria

* Undiagnosed or untreated sleep disorder

Design outcomes

Primary

MeasureTime frameDescription
Intervention Completion RateDay 1Assess the feasibility/rate of completion of sleep intervention discussion within the clinic session based on the percent of interventions completed for those who screened positive in the sleep screening.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORErin Cobry, MD

University Of Colorado, Barbara Davis Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026